Back to Search Start Over

Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies.

Authors :
Farini A
Villa C
Tripodi L
Legato M
Torrente Y
Source :
Frontiers in immunology [Front Immunol] 2021 Jul 14; Vol. 12, pp. 666879. Date of Electronic Publication: 2021 Jul 14 (Print Publication: 2021).
Publication Year :
2021

Abstract

Muscular dystrophies and inflammatory myopathies are heterogeneous muscular disorders characterized by progressive muscle weakness and mass loss. Despite the high variability of etiology, inflammation and involvement of both innate and adaptive immune response are shared features. The best understood immune mechanisms involved in these pathologies include complement cascade activation, auto-antibodies directed against muscular proteins or de-novo expressed antigens in myofibers, MHC-I overexpression in myofibers, and lymphocytes-mediated cytotoxicity. Intravenous immunoglobulins (IVIGs) administration could represent a suitable immunomodulator with this respect. Here we focus on mechanisms of action of immunoglobulins in muscular dystrophies and inflammatory myopathies highlighting results of IVIGs from pre-clinical and case reports evidences.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Farini, Villa, Tripodi, Legato and Torrente.)

Details

Language :
English
ISSN :
1664-3224
Volume :
12
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
34335568
Full Text :
https://doi.org/10.3389/fimmu.2021.666879